Your session is about to expire
← Back to Search
Proton Pump Inhibitor
Esomeprazole for Acid Reflux (ISS Trial)
Phase 2 & 3
Waitlist Available
Led By Ronnie Fass, MD
Research Sponsored by Southern Arizona VA Health Care System
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 years
Awards & highlights
Summary
The purpose of this study is to determine if esomeprazole 40 mg. once daily improves not only nighttime symptoms but also significantly reduces conscious awakenings associated with gastroesophageal reflux and consequently improves sleep quality.
Eligible Conditions
- Acid Reflux
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 2 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 years
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
The Effect of Esomeprazole 40 mg. Daily for 7 Days on Acid Reflux and Related Arousals During Sleep in Patients w/ GERD.
Trial Design
1Treatment groups
Experimental Treatment
Group I: EsomeprazoleExperimental Treatment2 Interventions
Effect of PPI esomeprazole on acid reflux \& related arousals during sleep in patients with GERD.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Esomeprazole
FDA approved
Esomeprazole
FDA approved
Find a Location
Who is running the clinical trial?
Southern Arizona VA Health Care SystemLead Sponsor
10 Previous Clinical Trials
888 Total Patients Enrolled
Ronnie Fass, MDPrincipal InvestigatorSAVAHCS
10 Previous Clinical Trials
399 Total Patients Enrolled
Share this study with friends
Copy Link
Messenger